Back to recall look-up

Recall archive

94,355 stored notices, from Jun 20, 2012 to Sep 23, 2026.

10 recalls · page 1 of 1

Drugs

Reported Nov 1, 2017

Enalapril Maleate tablets, USP, 5mg, 1000-count bottles, Rx only, Manufactured by: Wockhardt Limited H-14/2, M.I.D.C.…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Wockhardt USA Inc.

Matched: Brand · Product · Product detailsFailed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound.

FDA (openFDA drug enforcement)

Drugs

Reported Aug 26, 2015

Lisinopril Tablets USP, 5 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India;…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Wockhardt USA Inc.

Matched: Brand · Product · Product detailsCGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Jul 29, 2015

Amlodipine Besylate Tablets, 2.5 mg Tablets, Packaged in 90 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Wockhardt USA Inc.

Matched: Brand · Product · Product detailsCGMP Deviations: Firm did not adequately investigate customer complaints.

34 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported May 13, 2015

Captopril Tablets, USP 12.5 mg, Rx Only, a) 100 count bottles NDC 64679-902-01, b) 1000 count bottles NDC 64679-902-02,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Wockhardt USA Inc.

Matched: Brand · Product detailsFailed Tablet/Capsule Specifications: out of specification for thickness.

FDA (openFDA drug enforcement)

Drugs

Reported Dec 24, 2014

Wockhardt Metoprolol Succinate, Extended-Release Tablets USP, 50 mg, a)100-count HDPE bottle (NDC 64679-735-02), b)…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Wockhardt USA Inc.

Matched: Brand · Product · Product detailsFailed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long term stability testing point.

FDA (openFDA drug enforcement)

Drugs

Reported Aug 27, 2014

Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-count bottle (NDC 64679-737-02), b)…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Wockhardt USA Inc.

Matched: Brand · Product · Product detailsFailed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point.

FDA (openFDA drug enforcement)

Drugs

Reported Aug 13, 2014

buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, Rx Only, Manufactured by: Wockhardt

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Wockhardt USA Inc.

Matched: Brand · Product · Product detailsFailed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.

FDA (openFDA drug enforcement)

Drugs

Reported Jun 4, 2014

Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle, Rx only. Manufactured by: Wockhardt

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Wockhardt USA Inc.

Matched: Brand · Product · Product detailsFailed Dissolution Specifications: Failure of dissolution test observed at three month time point.

FDA (openFDA drug enforcement)

Drugs

Reported May 14, 2014

Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, Rx only, Manufactured by: Wockhardt

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Wockhardt USA Inc.

Matched: Brand · Product · Product detailsFailed Dissolution Specifications: failure of dissolution test observed at nine month time point.

FDA (openFDA drug enforcement)

Drugs

Reported Feb 5, 2014

Pantaprazole Sodium Delayed Release Tablets , USP 40 mg, 1000 tablets bottle, Rx only. Manufactured by: Wockhardt

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Wockhardt USA Inc.

Matched: Brand · Product · Product detailsFailed Dissolution Specifications; 12 month acid dissolution test results were above upper limit specifications.

FDA (openFDA drug enforcement)

RecallNow is not a government agency. Every notice above is published by the FDA, USDA FSIS, or CPSC and links back to its source. Back to the look-up